ArticlePloS one2024

CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy via liposomal-coated compounds.

Mai O Kadry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.